The efficacy of donepezil is well known for improving the cognitive performance in patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD).
Is Aricept used for mild cognitive impairment?
Donepezil (Aricept, E2020), a cholinesterase inhibitor, has been shown to benefit all severities of AD including mild and it would be reasonable to investigate its efficacy for those with MCI. Objectives: To assess the effects of donepezil in people with mild cognitive impairment but no diagnosis of dementia.
Does Aricept improve cognition?
Aricept is thought to increase acetylcholine levels in the brain by preventing the breakdown of acetylcholine. This can increase the communication between remaining healthy nerve cells in the brain, and provide a temporary reprieve from dementia linked to Alzheimer’s by improving cognition and function.
Does donepezil help with confusion?
Donepezil is used to treat confusion (dementia) related to Alzheimer’s disease. It does not cure Alzheimer’s disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.
How long is donepezil effective for?
Long term efficacy data suggest that improvements in cognition, global function or ADL are maintained for about 21 to 81 weeks with donepezil (10 mg/day in most patients). Donepezil is generally well tolerated with the majority of adverse events being mild and transient.
Can donepezil make memory worse?
Conclusion: There were no changes in global cognitive performance or dementia severity; however, a subgroup of patients with FTD can experience worsening of symptoms with donepezil.
Which medication has been approved as a treatment for mild cognitive impairment?
There are currently no drugs that have been approved for treating MCI, as opposed to dementia. It was initially hoped that the Alzheimer’s drugs donepezil (for example Aricept), rivastigmine (for example Exelon) and galantamine (for example Reminyl) would help with symptoms of MCI, or slow its progression to dementia.
When should donepezil be stopped?
These medications should be stopped if the desired effects—stabilizing cognitive and functional status—are not perceived within a reasonable time, such as 12 weeks. In some cases, stopping cholinesterase inhibitor therapy may cause negative effects on cognition and neuropsychiatric symptoms.
How well does donepezil work?
Donepezil is more effective than placebo and is well tolerated in improving the major symptoms of this disease. Improvements are usually modest, although stabilization of cognitive and functional symptoms with donepezil can also be considered an important clinical outcome. Donepezil may lessen caregiver burden.
Does donepezil make you smarter?
A study published in the journal Psychopharmacology of the affect of the Alzheimer’s drug Donepezil on 30 healthy male students conducted in Germany last year found that taking the drug for 30 days significantly improved short term memory and some long term memory faculties.
Can you still drive with mild cognitive impairment?
Although some drivers with mild dementia may continue to drive after the condition has been diagnosed, the ability to drive a motor vehicle safely is eventually lost as the disease progresses.
How long can a person live with mild cognitive impairment?
Women can expect to live 4.2 years with mild impairment and 3.2 with dementia, men 3.5 and 1.8 years.
Is donepezil effective for mild cognitive impairment with no dementia?
Donepezil (Aricept, E2020), a cholinesterase inhibitor, has been shown to benefit all severities of AD including mild and it would be reasonable to investigate its efficacy for those with MCI. To assess the effects of donepezil in people with mild cognitive impairment but no diagnosis of dementia.
How many patients are enrolled in a 24-week trial of donepezil?
Methods: A total of 270 patients with MCI were enrolled in a 24-week, multicenter, randomized, double-blind, placebo-controlled study. Patients were randomized to receive donepezil (n = 133; 5 mg/day for 42 days, followed by forced dose escalation to 10 mg/day) or placebo (n = 137).
How effective is donepezil 10 mg/day?
In the first study the 13-item ADAS-Cog showed benefit associated with 10 mg/day donepezil compared with placebo at 24 weeks (MD 1.90, 95% CI 0.51 to 3.29, p=0.007), but four other measures of cognitive function did not.
What is the role of donepezil in the treatment of vascular disease?
Deficits in acetylcholine mediated neurotransmission have been postulated in cognitive impairment due to vascular disease of the brain. Two large-scales randomized trials provide evidence of beneficial effects from donepezil at doses of 5 or 10 mg per day over 24 weeks.
